Pfizer Inc. (BIT:1PFE)
Italy · Delayed Price · Currency is EUR 22.90
+0.01 (0.04%)
Last updated: Mar 4, 2026, 2:01 PM CET
Pfizer Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 15,599 | 16,113 | 4,330 | 62,808 | 44,484 |
Depreciation & Amortization | 6,592 | 7,013 | 6,290 | 5,064 | 5,191 |
Stock-Based Compensation | 799 | 877 | 525 | 872 | 1,182 |
Other Adjustments | 1,856 | -143 | 1,901 | -2,437 | -8,279 |
Change in Receivables | -263 | -109 | 347 | 261 | -3,811 |
Changes in Inventories | 561 | -854 | -1,169 | -591 | -1,125 |
Changes in Accounts Payable | -469 | -1,023 | -300 | 1,191 | 1,242 |
Changes in Accrued Expenses | -3,667 | -3,115 | 595 | -1,449 | 18,721 |
Changes in Income Taxes Payable | -2,805 | -1,345 | -982 | -545 | -1,166 |
Changes in Other Operating Activities | 1,289 | 3,380 | -663 | -4,506 | -1,057 |
Operating Cash Flow | 11,704 | 12,744 | 8,700 | 29,267 | 32,580 |
Operating Cash Flow Growth | -8.16% | 46.48% | -70.27% | -10.17% | 126.20% |
Capital Expenditures | -2,629 | -2,909 | -3,907 | -3,236 | -2,711 |
Purchases of Investments | -14,650 | -10,313 | -31,178 | -38,297 | -39,525 |
Proceeds from Sale of Investments | 19,054 | 5,698 | 41,243 | 45,462 | 28,096 |
Payments for Business Acquisitions | -6,927 | - | -43,430 | -22,997 | - |
Proceeds from Business Divestments | 6,311 | 7,040 | - | - | - |
Other Investing Activities | -2,510 | 3,138 | 4,995 | 3,285 | -8,393 |
Investing Cash Flow | -1,351 | 2,652 | -32,278 | -15,783 | -22,546 |
Short-Term Debt Issued | -796 | 6,317 | 7,686 | 3,669 | -96 |
Short-Term Debt Repaid | -2,199 | -11,226 | -3 | -3,887 | - |
Net Short-Term Debt Issued (Repaid) | -2,995 | -4,909 | 7,683 | -218 | -96 |
Long-Term Debt Issued | 2,921 | -2,250 | 28,262 | -3,298 | -1,007 |
Net Long-Term Debt Issued (Repaid) | 2,921 | -2,250 | 28,262 | -3,298 | -1,007 |
Repurchase of Common Stock | - | - | - | -2,000 | - |
Net Common Stock Issued (Repurchased) | - | - | - | -2,000 | - |
Common Dividends Paid | -9,771 | -9,512 | -9,247 | -8,983 | -8,729 |
Other Financing Activities | -458 | -469 | -631 | -335 | 16 |
Financing Cash Flow | -10,304 | -17,140 | 26,066 | -14,834 | -9,816 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 41 | -66 | -40 | -165 | -59 |
Net Cash Flow | 91 | -1,810 | 2,448 | -1,515 | 159 |
Free Cash Flow | 9,075 | 9,835 | 4,793 | 26,031 | 29,869 |
Free Cash Flow Growth | -7.73% | 105.19% | -81.59% | -12.85% | 145.29% |
FCF Margin | 14.50% | 15.46% | 8.05% | 25.73% | 36.74% |
Free Cash Flow Per Share | 1.59 | 1.73 | 0.84 | 4.54 | 5.23 |
Levered Free Cash Flow | 6,569 | 2,019 | 37,928 | 23,784 | 39,971 |
Unlevered Free Cash Flow | 6,658 | 9,198 | 2,035 | 27,327 | 41,554 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.